SEC Company Response from enVVeno Medical Corp (NVNO, NVNBW) (CIK 0001661053) (NVNO) — Aug 21, 2023

enVVeno Medical Corp (NVNO, NVNBW) (CIK 0001661053)
Date: Aug. 21, 2023 · CIK: 0001661053 · Accession: 0001493152-23-029696

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-273546

Date

Aug. 21, 2023

Author

Chief

Form

CORRESP

Company

enVVeno Medical Corp (NVNO, NVNBW) (CIK 0001661053)

Letter

VIA EDGAR Division of Corporation Finance Office of Life Sciences Re: enVVeno Medical Corporation Registration Statement on Form S-3 Filed July 31, 2023, as amended File No. 333-273546

Dear Ms. Park:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation, hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Wednesday, August 23, 2023, or as soon as thereafter practicable.

Very
truly yours,
/s/
Robert Berman

Show Raw Text

CORRESP
1
filename1.htm

ENVVENO
MEDICAL CORPORATION

70
Doppler

Irvine,
California 92618

August
21, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
DC 20549

Attn:
Jane Park

    Re:
    enVVeno
    Medical Corporation

    Registration
    Statement on Form S-3

    Filed
    July 31, 2023, as amended

    File
    No. 333-273546

Dear
Ms. Park:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation, hereby requests acceleration of effectiveness
of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Wednesday, August 23, 2023, or as
soon as thereafter practicable.

    Very
    truly yours,

    /s/
    Robert Berman

    Robert
    Berman

    Chief
    Executive Officer

    cc:
    Ellenoff
    Grossman & Schole LLP

SecProbe.io